It will reduce the time for processing reimbursement applications by a third and be about half a million zlotys cheaper for the responsible entity in the case of cardiovascular drugs with well-established efficacy. The Health Ministry has announced a list of substances covered by such a procedure. A similar one is being prepared for oncology indications.
- Drugs with well-established clinical efficacy are those whose effectiveness and safety have been confirmed in numerous clinical trials and through long periods of use in clinical practice. They are effective and safe for treating diseases, and we know this based on empirical evidence and data. Responsible entities whose drug technologies are on the list can apply for reimbursement through the Refund List Service System," Deputy Health Minister Marek Kos explained at Friday's press conference.
As ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
